News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dickinson Andrew D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,219 shares
@ $78.12, valued at
$95.2k
Exercised 2,618 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 4,849 shares
@ $79.5, valued at
$385.5k
Exercised 3,025 restricted stock units
@ $0
Exercised 7,394 restricted stock units
@ $0
Granted 16,350 restricted stock units
@ $0
Granted 74,565 options to buy
@ $79.5, valued at
$5.9M
|
|
| 02/23/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 376 shares
@ $56.3805, valued at
$21.2k
|
|
| 02/07/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 531 shares
@ $86.36, valued at
$45.9k
Exercised 1,817 restricted stock units
@ $0 |
|
| 01/26/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 27,932 shares
@ $0
Granted 38,270 shares
@ $0
Paid exercise price by delivering 15,327 shares
@ $84.02, valued at
$1.3M
|
|
| 12/13/2022 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 480 shares
@ $87.97, valued at
$42.2k
Exercised 1,027 restricted stock units
@ $0 |
|
| 09/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2022 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 348 shares
@ $52.1305, valued at
$18.1k
|
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 19,020 shares
@ $0
Granted 13,156 shares
@ $0
Paid exercise price by delivering 3,616 shares
@ $67.34, valued at
$243.5k
|
|
| 11/12/2021 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 870 shares
@ $67.32, valued at
$58.6k
Exercised 1,913 restricted stock units
@ $0 |
|
| 08/24/2021 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 1 shares
@ $55.08, valued at
$55.1 |
|
| 06/14/2021 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 1,605 shares
@ $69.29, valued at
$111.2k
Exercised 3,646 restricted stock units
@ $0 |
|
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Dickinson Andrew D (EVP, CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 1,399 shares
@ $60.62, valued at
$84.8k
Exercised 1,133 restricted stock units
@ $0
Exercised 1,913 restricted stock units
@ $0 |
|
| 08/12/2020 |
4
| Dickinson Andrew D (EVP, CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 1,022 shares
@ $68.51, valued at
$70k
Exercised 2,306 restricted stock units
@ $0 |
|
| 06/12/2020 |
4
| Dickinson Andrew D (EVP, CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Paid exercise price by delivering 1,691 shares
@ $77.07, valued at
$130.3k
Exercised 3,646 restricted stock units
@ $0 |
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2020 |
4
| Dickinson Andrew D (EVP, CFO) has filed a Form 4 on GILEAD SCIENCES INC|
Txns:
| Granted 3,834 shares
@ $0 |
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2019 |
3
| Dickinson Andrew D (EVP, CFO) has filed a Form 3 on GILEAD SCIENCES INC |
|
|